
Indaptus Therapeutics, Inc.
INDPHealthcare|Biotechnology|US
$3.32
+0.16 (+5.06%)
DCF Value
$8.29
Tangible Book / Share
$0.10
Cash / Share
$0.10
Next Earnings Report
Nov 17, 2026
EPS est. -$1.46
Financing Filings (last 12 months)
5
Shelf registrations / offering prospectuses — latest Sep 4, 2026 (424B5). Possible dilution.
Upcoming Data Readouts (1)
Jun 2027
Est. completion
P1P2Solid Tumor, Adult
Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors
NCT05651022n=120
Recent Press Releases
Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 13, 2026 · GlobeNewsWire
SEC Filings (98)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 22, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Oct 22, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Oct 22, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Oct 21, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Oct 20, 2026 | 8-K | Material event | DocumentIndex |
| Oct 5, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Sep 30, 2026 | 8-K | Material event | DocumentIndex |
| Sep 10, 2026 | 8-K | Material event | DocumentIndex |
| Sep 8, 2026 | 8-K/A | Material event | DocumentIndex |
| Sep 4, 2026 | 8-K | Material event | DocumentIndex |
| Sep 4, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Sep 1, 2026 | 8-K | Material event | DocumentIndex |
| Aug 31, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Aug 26, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Aug 25, 2026 | EFFECT | DocumentIndex | |
| Aug 17, 2026 | S-3 | Shelf registration | DocumentIndex |
| Aug 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 13, 2026 | 8-K | Material event | DocumentIndex |
| Jul 17, 2026 | EFFECT | DocumentIndex | |
| Jul 16, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Jun 26, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Jun 26, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Jun 26, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Jun 26, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Jun 26, 2026 | S-3 | Shelf registration | DocumentIndex |
| Jun 24, 2026 | 8-K | Material event | DocumentIndex |
| Jun 22, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Jun 5, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 15, 2026 | 8-K | Material event | DocumentIndex |
| Apr 29, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Apr 24, 2026 | 8-K/A | Material event | DocumentIndex |
| Apr 23, 2026 | 8-K | Material event | DocumentIndex |
| Apr 6, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Apr 3, 2026 | 8-K | Material event | DocumentIndex |
| Mar 30, 2026 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| Mar 24, 2026 | 8-K | Material event | DocumentIndex |
| Mar 24, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Mar 17, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 2, 2026 | SC 13D | Activist / 5%+ stake | DocumentIndex |